JP2023537958A5 - - Google Patents
Info
- Publication number
- JP2023537958A5 JP2023537958A5 JP2023509554A JP2023509554A JP2023537958A5 JP 2023537958 A5 JP2023537958 A5 JP 2023537958A5 JP 2023509554 A JP2023509554 A JP 2023509554A JP 2023509554 A JP2023509554 A JP 2023509554A JP 2023537958 A5 JP2023537958 A5 JP 2023537958A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010842370 | 2020-08-20 | ||
| CN202010842370.5 | 2020-08-20 | ||
| PCT/CN2021/112756 WO2022037527A1 (zh) | 2020-08-20 | 2021-08-16 | 结合bcma的单可变结构域及抗原结合分子 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2023537958A JP2023537958A (ja) | 2023-09-06 |
| JPWO2022037527A5 JPWO2022037527A5 (https=) | 2024-08-26 |
| JP2023537958A5 true JP2023537958A5 (https=) | 2024-08-26 |
| JP7821159B2 JP7821159B2 (ja) | 2026-02-26 |
Family
ID=80323410
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023509554A Active JP7821159B2 (ja) | 2020-08-20 | 2021-08-16 | Ｂｃｍａと結合する単一可変ドメイン及び抗原結合分子 |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP4202047A4 (https=) |
| JP (1) | JP7821159B2 (https=) |
| KR (1) | KR20230045066A (https=) |
| CN (1) | CN115715325A (https=) |
| WO (1) | WO2022037527A1 (https=) |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4282877A3 (en) | 2016-08-10 | 2024-02-21 | Legend Biotech Ireland Limited | Chimeric antigen receptors targeting bcma and methods of use thereof |
| BR112020006248A8 (pt) * | 2017-09-29 | 2023-03-21 | Mogam Inst Biomedical Res | Anticorpo anti-bcma com alta afinidade para bcma, polinucleotídeo, vetor de expressão, célula hospedeira, método para produção do dito anticorpo, composição farmacêutica compreendendo o mesmo e uso do anticorpo para prevenção ou tratamento de câncer |
| UY38251A (es) * | 2018-06-01 | 2019-12-31 | Novartis Ag | Moléculas de unión contra bcma y usos de las mismas |
| EP3845244A4 (en) * | 2018-08-24 | 2022-09-07 | Shenzhen Pregene Biopharma Co. Ltd. | ANTI-BCMA SINGLE DOMAIN ANTIBODIES AND THEIR USE |
| CN109942708B (zh) * | 2019-03-28 | 2021-01-05 | 上海科棋药业科技有限公司 | 一种抗bcma的单域抗体及其应用 |
| CN109942709B (zh) * | 2019-04-22 | 2019-12-27 | 广州百暨基因科技有限公司 | 一种抗bcma的单域抗体及其应用 |
| CN111333729B (zh) * | 2020-03-17 | 2022-12-06 | 深圳市南科生物工程有限公司 | 抗b细胞成熟抗原的纳米抗体及应用 |
| CN117062840A (zh) * | 2021-04-15 | 2023-11-14 | 正大天晴药业集团股份有限公司 | 靶向bcma的多特异性抗体 |
-
2021
- 2021-08-16 KR KR1020237007603A patent/KR20230045066A/ko active Pending
- 2021-08-16 WO PCT/CN2021/112756 patent/WO2022037527A1/zh not_active Ceased
- 2021-08-16 EP EP21857622.1A patent/EP4202047A4/en active Pending
- 2021-08-16 JP JP2023509554A patent/JP7821159B2/ja active Active
- 2021-08-16 CN CN202180041380.1A patent/CN115715325A/zh active Pending